Education
About Us
Working with TipRanks
Follow Us
AIM Vaccine Co., Ltd. Class H (HK:6660)
:6660
Total Valuation
AIM Vaccine Co., Ltd. Class H has a market cap or net worth of ―. The enterprise value is HK$6.31B.
Market Cap―
Enterprise ValueHK$6.31B
Share Statistics
AIM Vaccine Co., Ltd. Class H has 507,673,700 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding507,673,700
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
AIM Vaccine Co., Ltd. Class H’s return on equity (ROE) is -0.08 and return on invested capital (ROIC) is -3.59%.
Return on Equity (ROE)-0.08
Return on Assets (ROA)-0.04
Return on Invested Capital (ROIC)-3.59%
Return on Capital Employed (ROCE)-0.05
Revenue Per Employee837.15K
Profits Per Employee-189.39K
Employee Count1,535
Asset Turnover0.18
Inventory Turnover0.72
Valuation Ratios
The current PE Ratio of AIM Vaccine Co., Ltd. Class H is ―. AIM Vaccine Co., Ltd. Class H’s PEG ratio is ―.
PE Ratio―
PS Ratio0.00
PB Ratio0.00
Price to Fair Value2.07
Price to FCF0.00
Price to Operating Cash Flow-40.67
PEG Ratio―
Income Statement
In the last 12 months, AIM Vaccine Co., Ltd. Class H had revenue of 1.29B and earned -277.23M in profits. Earnings per share was -0.23.
Revenue1.29B
Gross Profit953.51M
Operating Income-210.91M
Pretax Income-290.72M
Net Income-277.23M
EBITDA-87.37M
Earnings Per Share (EPS)-0.23
Cash Flow
In the last 12 months, operating cash flow was -97.16M and capital expenditures -50.63M, giving a free cash flow of -147.79M billion.
Operating Cash Flow-97.16M
Free Cash Flow-147.79M
Free Cash Flow per Share-0.29
Dividends & Yields
AIM Vaccine Co., Ltd. Class H pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta2.18
52-Week Price Change-70.94%
50-Day Moving Average4.91
200-Day Moving Average4.69
Relative Strength Index (RSI)27.99
Average Volume (3m)2.06M
Important Dates
AIM Vaccine Co., Ltd. Class H upcoming earnings date is Mar 26, 2026, TBA (Not Confirmed).
Last Earnings DateAug 27, 2025
Next Earnings DateMar 26, 2026
Ex-Dividend Date―
Financial Position
AIM Vaccine Co., Ltd. Class H as a current ratio of 0.77, with Debt / Equity ratio of 54.71%
Current Ratio0.77
Quick Ratio0.62
Debt to Market Cap0.26
Net Debt to EBITDA-15.42
Interest Coverage Ratio0.00
Taxes
In the past 12 months, AIM Vaccine Co., Ltd. Class H has paid -12.25M in taxes.
Income Tax-12.25M
Effective Tax Rate0.04
Enterprise Valuation
AIM Vaccine Co., Ltd. Class H EV to EBITDA ratio is -94.97, with an EV/FCF ratio of 0.00.
EV to Sales6.46
EV to EBITDA-94.97
EV to Free Cash Flow0.00
EV to Operating Cash Flow0.00
Balance Sheet
AIM Vaccine Co., Ltd. Class H has HK$594.87M in cash and marketable securities with HK$1.84B in debt, giving a net cash position of -HK$1.25B billion.
Cash & Marketable SecuritiesHK$594.87M
Total DebtHK$1.84B
Net Cash-HK$1.25B
Net Cash Per Share-HK$2.46
Tangible Book Value Per ShareHK$1.95
Margins
Gross margin is 74.20%, with operating margin of -16.41%, and net profit margin of -21.57%.
Gross Margin74.20%
Operating Margin-16.41%
Pretax Margin-22.62%
Net Profit Margin-21.57%
EBITDA Margin-6.80%
EBIT Margin-17.89%
Analyst Forecast
The average price target for AIM Vaccine Co., Ltd. Class H is HK$4.50, which is 11.43% higher than the current price. The consensus rating is Hold
Price TargetHK$4.50
Price Target Upside12.78% Upside
Analyst ConsensusHold
Analyst Count0
Revenue Growth Forecast6.48%
EPS Growth Forecast77.50%